
Minds AI builds diagnostic and therapeutic tools to make mental health screening and treatment more objective and accessible. The company combines AI models with salivary biomarker assays to power a depression screening product (Minds.NAVI) and delivers a clinically validated VR-based digital therapeutic (CHEEU.Forest). Its stack includes machine learning, biomarker testing, and immersive VR software, positioning it as a medtech/digital health B2B solution for clinics and mental health providers. Minds AI emphasizes clinical performance metrics and institutional deployment across healthcare settings.

Minds AI builds diagnostic and therapeutic tools to make mental health screening and treatment more objective and accessible. The company combines AI models with salivary biomarker assays to power a depression screening product (Minds.NAVI) and delivers a clinically validated VR-based digital therapeutic (CHEEU.Forest). Its stack includes machine learning, biomarker testing, and immersive VR software, positioning it as a medtech/digital health B2B solution for clinics and mental health providers. Minds AI emphasizes clinical performance metrics and institutional deployment across healthcare settings.